Hong Seng Consolidated Berhad Past Earnings Performance
Past criteria checks 0/6
Hong Seng Consolidated Berhad has been growing earnings at an average annual rate of 22.2%, while the Healthcare industry saw earnings growing at 21.8% annually. Revenues have been growing at an average rate of 33.2% per year.
Key information
22.2%
Earnings growth rate
35.5%
EPS growth rate
| Healthcare Industry Growth | 31.5% |
| Revenue growth rate | 33.2% |
| Return on equity | -21.9% |
| Net Margin | -409.6% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Hong Seng Consolidated Berhad (KLSE:HONGSENG) Has Debt But No Earnings; Should You Worry?
Sep 23
Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?
Jun 09Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?
Oct 12Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?
May 11We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt
Jan 27Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching
Jan 04Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings
Nov 30Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns
Oct 26Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
Aug 31We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease
Aug 09Revenue & Expenses Breakdown
How Hong Seng Consolidated Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 15 | -61 | 14 | 0 |
| 30 Jun 23 | 9 | -27 | 17 | 0 |
| 31 Mar 23 | 12 | -3 | 19 | 0 |
| 31 Dec 22 | 126 | 49 | 23 | 0 |
| 30 Sep 22 | 198 | 97 | 25 | 0 |
| 30 Jun 22 | 257 | 135 | 24 | 0 |
| 31 Mar 22 | 258 | 118 | 21 | 0 |
| 31 Dec 21 | 196 | 82 | 17 | 0 |
| 30 Sep 21 | 146 | 44 | 12 | 0 |
| 31 Dec 20 | 27 | -4 | 5 | 0 |
| 30 Sep 20 | 2 | -7 | 5 | 0 |
| 30 Jun 20 | 3 | -8 | 4 | 0 |
| 31 Mar 20 | 4 | -7 | 5 | 0 |
| 31 Dec 19 | 5 | -7 | 2 | 0 |
| 30 Sep 19 | 8 | -13 | 4 | 0 |
| 30 Jun 19 | 10 | -14 | 4 | 0 |
| 31 Mar 19 | 10 | -13 | 6 | 0 |
| 31 Dec 18 | 16 | -26 | 6 | 0 |
| 30 Sep 18 | 24 | -20 | 6 | 0 |
| 30 Jun 18 | 26 | -24 | 8 | 0 |
| 31 Mar 18 | 29 | -27 | 9 | 0 |
| 31 Dec 17 | 27 | -10 | 15 | 0 |
| 30 Sep 17 | 27 | -12 | 14 | 0 |
| 30 Jun 17 | 29 | -11 | 14 | 0 |
| 31 Mar 17 | 30 | -8 | 12 | 0 |
| 31 Dec 16 | 31 | -8 | 12 | 0 |
| 30 Sep 16 | 38 | -3 | 14 | 0 |
| 30 Jun 16 | 39 | 1 | 13 | 0 |
| 31 Mar 16 | 42 | 2 | 14 | 0 |
| 31 Dec 15 | 42 | 4 | 14 | 0 |
| 30 Sep 15 | 39 | -2 | 12 | 0 |
| 30 Jun 15 | 39 | -5 | 15 | 0 |
| 31 Mar 15 | 38 | -5 | 16 | 0 |
| 31 Dec 14 | 36 | -9 | 18 | 0 |
| 30 Sep 14 | 33 | -2 | 16 | 0 |
| 30 Jun 14 | 35 | 1 | 16 | 0 |
| 31 Mar 14 | 34 | 2 | 16 | 0 |
Quality Earnings: HONGSENG is currently unprofitable.
Growing Profit Margin: HONGSENG is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HONGSENG is unprofitable, but has reduced losses over the past 5 years at a rate of 22.2% per year.
Accelerating Growth: Unable to compare HONGSENG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HONGSENG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2.4%).
Return on Equity
High ROE: HONGSENG has a negative Return on Equity (-21.92%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 15:04 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hong Seng Consolidated Berhad is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Terence Wong | CGS International |
| Shin Kao | OSK-DMG |
| Swee Tyng Chin | TA Securities Holdings Berhad |